PMC:7212965 / 62320-62554 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T144","span":{"begin":139,"end":144},"obj":"Body_part"}],"attributes":[{"id":"A144","pred":"fma_id","subj":"T144","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":"n = 81Survival: NRInclusion: Inpatients with COVID-19 (RT-PCR on nasal and pharyngeal swabs)Age: M 38 y (IQR, 34.5–42.5 y)Sex: 0% femaleGI/liver comorbidities: NRDisease severity: 2.5% mild, 86.4% moderate, 8.6% severe, 2.5% critical."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T112","span":{"begin":139,"end":144},"obj":"Body_part"}],"attributes":[{"id":"A112","pred":"uberon_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":"n = 81Survival: NRInclusion: Inpatients with COVID-19 (RT-PCR on nasal and pharyngeal swabs)Age: M 38 y (IQR, 34.5–42.5 y)Sex: 0% femaleGI/liver comorbidities: NRDisease severity: 2.5% mild, 86.4% moderate, 8.6% severe, 2.5% critical."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T313","span":{"begin":45,"end":53},"obj":"Disease"}],"attributes":[{"id":"A313","pred":"mondo_id","subj":"T313","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"n = 81Survival: NRInclusion: Inpatients with COVID-19 (RT-PCR on nasal and pharyngeal swabs)Age: M 38 y (IQR, 34.5–42.5 y)Sex: 0% femaleGI/liver comorbidities: NRDisease severity: 2.5% mild, 86.4% moderate, 8.6% severe, 2.5% critical."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T442","span":{"begin":139,"end":144},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T443","span":{"begin":139,"end":144},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"}],"text":"n = 81Survival: NRInclusion: Inpatients with COVID-19 (RT-PCR on nasal and pharyngeal swabs)Age: M 38 y (IQR, 34.5–42.5 y)Sex: 0% femaleGI/liver comorbidities: NRDisease severity: 2.5% mild, 86.4% moderate, 8.6% severe, 2.5% critical."}

{"project":"LitCovid-sentences","denotations":[{"id":"T469","span":{"begin":29,"end":96},"obj":"Sentence"},{"id":"T470","span":{"begin":97,"end":126},"obj":"Sentence"},{"id":"T471","span":{"begin":127,"end":179},"obj":"Sentence"},{"id":"T472","span":{"begin":180,"end":234},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"n = 81Survival: NRInclusion: Inpatients with COVID-19 (RT-PCR on nasal and pharyngeal swabs)Age: M 38 y (IQR, 34.5–42.5 y)Sex: 0% femaleGI/liver comorbidities: NRDisease severity: 2.5% mild, 86.4% moderate, 8.6% severe, 2.5% critical."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2365","span":{"begin":45,"end":53},"obj":"Disease"}],"attributes":[{"id":"A2365","pred":"tao:has_database_id","subj":"2365","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"n = 81Survival: NRInclusion: Inpatients with COVID-19 (RT-PCR on nasal and pharyngeal swabs)Age: M 38 y (IQR, 34.5–42.5 y)Sex: 0% femaleGI/liver comorbidities: NRDisease severity: 2.5% mild, 86.4% moderate, 8.6% severe, 2.5% critical."}